eGenesis
Healthcare & Life Sciences
Recent Finacing
Series D
Recent Raise
$191M
eGenesis is a biotechnology company developing genetically engineered organs to address the global organ shortage, with a focus on advancing their lead product candidate for kidney transplants.
Focus Areas
biotechnology
kidney transplants
genetically engineered organs
organ shortage
porcine kidney transplant
FDA authorization
Investors
